Zacks: Brokerages Expect Tivity Health, Inc. (NASDAQ:TVTY) Will Announce Quarterly Sales of $135.00 Million

Wall Street analysts expect that Tivity Health, Inc. (NASDAQ:TVTY – Get Rating) will announce sales of $135.00 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Tivity Health’s earnings, with the lowest sales estimate coming in at $132.80 million and the highest estimate coming in at $139.10 million. Tivity Health reported sales of $120.07 million in the same quarter last year, which would suggest a positive year over year growth rate of 12.4%. The company is expected to issue its next quarterly earnings results on Monday, January 1st.

On average, analysts expect that Tivity Health will report full year sales of $552.25 million for the current fiscal year, with estimates ranging from $541.19 million to $565.73 million. For the next year, analysts anticipate that the company will post sales of $613.20 million, with estimates ranging from $596.01 million to $636.27 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that cover Tivity Health.

Tivity Health (NASDAQ:TVTY – Get Rating) last released its earnings results on Thursday, May 5th. The company reported $0.40 EPS for the quarter, missing the consensus estimate of $0.42 by ($0.02). The company had revenue of $127.51 million for the quarter, compared to analyst estimates of $132.21 million. Tivity Health had a net margin of 17.25% and a return on equity of 75.94%. The firm’s quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.40 EPS.

TVTY has been the subject of a number of research reports. William Blair reissued a “market perform” rating on shares of Tivity Health in a research report on Thursday, February 24th. Barrington Research cut Tivity Health from an “outperform” rating to a “market perform” rating in a research report on Tuesday, April 5th. Zacks Investment Research downgraded Tivity Health from a “hold” rating to a “sell” rating in a report on Tuesday. StockNews.com began coverage on Tivity Health in a research report on Thursday, March 31st. They issued a “hold” rating for the company. Finally, Credit Suisse Group raised their price target on Tivity Health from $29.00 to $31.00 and gave the company a “neutral” rating in a report on Friday, March 11th. One analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $30.67.

Several large investors have recently bought and sold shares of the company. Morgan Stanley boosted its stake in Tivity Health by 336.2% in the third quarter. Morgan Stanley now owns 3,503,870 shares of the company’s stock valued at $80,798,000 after acquiring an additional 2,700,648 shares during the last quarter. Norges Bank bought a new stake in Tivity Health during the 4th quarter worth approximately $16,828,000. BlackRock Inc. increased its stake in Tivity Health by 7.3% in the third quarter. BlackRock Inc. now owns 6,937,974 shares of the company’s stock valued at $159,989,000 after acquiring an additional 474,654 shares during the last quarter. Patient Capital Management LLC purchased a new position in shares of Tivity Health in the 4th quarter worth about $9,106,000. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Tivity Health by 107.5% in the 1st quarter. JPMorgan Chase & Co. now owns 557,828 shares of the company’s stock worth $17,945,000 after purchasing an additional 288,972 shares in the last quarter. 91.54% of the stock is owned by institutional investors.

Tivity Health stock opened at $31.87 on Friday. Tivity Health has a fifty-two week low of $21.25 and a fifty-two week high of $32.89. The company has a debt-to-equity ratio of 2.97, a current ratio of 2.47 and a quick ratio of 2.24. The company has a market cap of $1.59 billion, a P/E ratio of 18.64, a price-to-earnings-growth ratio of 1.76 and a beta of 2.14. The firm’s 50 day simple moving average is $31.31 and its 200-day simple moving average is $27.78.

Tivity Health Company Profile (Get Rating)

Tivity Health, Inc provides fitness and health products and solutions in the United States. The company offers SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans; Prime Fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; virtual fitness experiences, including live instructor-led classes; and WholeHealth living program, a continuum of services related to complementary, alternative, and physical medicine.

Featured Stories

• Get a free copy of the StockNews.com research report on Tivity Health (TVTY)
• The Three Most Upgraded Stocks You Can Buy Now 
• MarketBeat: Week in Review 5/9 – 5/13
• Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
• Beyond Meat Stock Value is Improving
• The Travel Sector Is Getting Upgraded 

Get a free copy of the Zacks research report on Tivity Health (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Want More Great Investing Ideas?